Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans-Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso-Ramos, Jorge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S. Hobbs, Ronald Hoffman, Elias J. Jabbour, Jean-Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L.-C. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte Niemeyer, Olatoyosi M. Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P. Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A. Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi

Blood (2022) 140 (11): 1200–1228.

https://doi.org/10.1182/blood.2022015850

Published: 2022

Includes: Supplemental data

Journal Articles

Essential Thrombocythemia Versus Pre-Fibrotic/Early Primary Myelofibrosis: Discrimination By Laboratory and Clinical Data

Martin Schalling, Andreas Gleiss, Bettina Gisslinger, Albert Wölfler, Veronika Buxhofer-Ausch, Georg Jeryczynski, MD, Maria-Theresa Krauth, MD, Ingrid Simonitsch-Klupp, MD, Christine Beham-Schmid, Jurgen Thiele, Heinz Gisslinger

Blood (2017) 130 (Supplement 1): 4201.

https://doi.org/10.1182/blood.V130.Suppl_1.4201.4201

Published: 2017

Journal Articles

Prefibrotic Primary Myelofibrosis As an Entity Distinct from Other Philadelphia-Chromosome Negative Myeloproliferative Neoplasms - Data from the Austrian Reclassification Project

Georg Jeryczynski, MD, Bettina Gisslinger, Martin Schalling, Maria Theresa Krauth, MD, Leonhard Muellauer, MD, Ana-Iris Schiefer, MD, Christoph Kornauth, MD, Ingrid Simonitsch-Klupp, MD, Jürgen Thiele, MD PhD, Heinz Gisslinger

Blood (2016) 128 (22): 4252.

https://doi.org/10.1182/blood.V128.22.4252.4252

Published: 2016

Journal Articles

Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological Diagnosis

Georg Jeryczynski, MD, Albert Woelfler, MD, Bettina Gisslinger, Martin Schalling, Sonja Burgstaller, MD, Veronika Buxhofer-Ausch, Maria Theresa Krauth, MD, Klaus Geissler, MD, Ernst Schlögl, MD, Thamer Sliwa, MD, Ana-Iris Schiefer, MD, Leonhard Muellauer, MD, Ingrid Simonitsch-Klupp, MD, Christine Beham-Schmid, MD, Jürgen Thiele, MDPhD, Heinz Gisslinger

Blood (2016) 128 (22): 1932.

https://doi.org/10.1182/blood.V128.22.1932.1932

Published: 2016

Journal Articles

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J. Borowitz, Michelle M. Le Beau, Clara D. Bloomfield, Mario Cazzola, James W. Vardiman

Blood (2016) 127 (20): 2391–2405.

https://doi.org/10.1182/blood-2016-03-643544

Published: 2016

Includes: Supplemental data

Journal Articles

In Contemporary Patients with Polycythemia Vera, Rates of Thrombosis and Risk Factors Delineate a New Clinical Epidemiology

Tiziano Barbui, MD, Alessandra Carobbio, MSc, Elisa Rumi, MD, Guido Finazzi, MD, Heinz Gisslinger, MD, Francesco Rodeghiero, Maria Luigia Randi, MD, Alessandro Rambaldi, Bettina Gisslinger, MSc, Lisa Pieri, MD PhD, Irene Bertozzi, Ilaria Carola Casetti, MD, Leonhard Müllauer, MD, Animesh Pardanani, MBBS, PhD, Jürgen Thiele, MD PhD, Francesco Passamonti, MD, Alessandro M. Vannucchi, MD, Ayalew Tefferi, MD

Blood (2014) 124 (21): 1822.

https://doi.org/10.1182/blood.V124.21.1822.1822

Published: 2014

Journal Articles

Effects Of Five-Years Of Ruxolitinib Therapy On Bone Marrow Morphology In Patients With Myelofibrosis and Comparison With Best Available Therapy

Hans Michael Kvasnicka, MD, PhD, Jürgen Thiele, MD, PhD, Carlos E. Bueso-Ramos, MD, PhD, William Sun, PhD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD, PhD

Blood (2013) 122 (21): 4055.

https://doi.org/10.1182/blood.V122.21.4055.4055

Published: 2013

Journal Articles

Correlation Of Longitudinal Blood Counts With Thromboembolic Complications In WHO 2008 Defined Prefibrotic Primary Myelofibrosis

Veronika Buxhofer-Ausch, Martin Schalling, Sophie Frantal, Jürgen Thiele, MD, PhD, Leonhard Muellauer, M.D., Hans-Michael Kvasnicka, MD, Bettina Gisslinger, Heinz Gisslinger, MD

Blood (2013) 122 (21): 2834.

https://doi.org/10.1182/blood.V122.21.2834.2834

Published: 2013

Journal Articles

Masked Polycythemia Vera (mPV): Results Of An International Study

Tiziano Barbui, MD, Jürgen Thiele, MD, PhD, Heinz Gisslinger, MD, Guido Finazzi, Alessandra Carobbio, MSc, Elisa Rumi, MD, Maria Luigia Randi, MD, Alessandro M. Vannucchi, MD, Lisa Pieri, MD, PhD, Bettina Gisslinger, Leonhard Muellauer, M.D., Marco Ruggeri, MD, Alessandro Rambaldi, MD, Ayalew Tefferi, MD

Blood (2013) 122 (21): 1581.

https://doi.org/10.1182/blood.V122.21.1581.1581

Published: 2013

Journal Articles

Effect Of Treatment With The JAK2-Selective Inhibitor Fedratinib (SAR302503) On Bone Marrow Histology In Patients With Myeloproliferative Neoplasms With Myelofibrosis

Catriona HM Jamieson, MD, PhD, Robert P Hasserjian, MD, Jason Gotlib, MD, MS, Jorge E. Cortes, MD, Richard M. Stone, MD, Moshe Talpaz, MD, Jürgen Thiele, MD, PhD, Scott J Rodig, MD, PhD, Abhay Patki, PhD MBA, Kaida Wu, PhD, MD, Jingyang Wu, MSc, Olga Pozdnyakova, MD, PhD

Blood (2013) 122 (21): 2823.

https://doi.org/10.1182/blood.V122.21.2823.2823

Published: 2013

Journal Articles

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Blood (2012) 120 (6): 1197–1201.

https://doi.org/10.1182/blood-2012-01-403279

Published: 2012

Includes: Supplemental data

Journal Articles

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis

Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Francesco Passamonti, Elisa Rumi, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, Heinz Gisslinger, Bettina Gisslinger, Guido Finazzi, Marco Ruggeri, Francesco Rodeghiero, Alessandro Rambaldi, Naseema Gangat, Ayalew Tefferi

Blood (2012) 120 (3): 569–571.

https://doi.org/10.1182/blood-2012-01-407981

Published: 2012

Includes: Supplemental data

Journal Articles

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

Blood (2012) 119 (10): 2239–2241.

https://doi.org/10.1182/blood-2011-11-393819

Published: 2012

Journal Articles

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

Jürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, Veronika Buxhofer-Ausch, Bettina Gisslinger, Heinz Gisslinger

Blood (2011) 117 (21): 5710–5718.

https://doi.org/10.1182/blood-2010-07-293761

Published: 2011

Journal Articles

Response: Factors considered in the 2008 WHO classification of myeloid neoplasms and acute leukemias

James Vardiman, Jürgen Thiele, Daniel A. Arber, Richard Brunning, Michael J. Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M. Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi, Clara D. Bloomfield

Blood (2010) 115 (3): 749–750.

https://doi.org/10.1182/blood-2009-11-250399

Published: 2010

Journal Articles

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Blood (2009) 114 (26): 5264–5270.

https://doi.org/10.1182/blood-2009-07-234880

Published: 2009

Journal Articles

Glivec/STI571 Treatment Stimulates Megakaryopoiesis and Normalizes PDGF Receptor beta Kinase Expression in Thrombocytopenic Patients with Myeloid Metaplasia with Myelofibrosis.

Marie Caroline le Bousse-Kerdiles, Christophe Desterke, Bernadette Guerton, Denis Clay, Hans Hasselbalch, Heinz Gisslinger, Jurgen Thiele, Hans Kvasnicka, Giovanni Barosi

Blood (2005) 106 (11): 2599.

https://doi.org/10.1182/blood.V106.11.2599.2599

Published: 2005

Journal Articles

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

Giovanni Barosi, Dominique Bordessoule, Jean Briere, Francisco Cervantes, Jean-Loup Demory, Brigitte Dupriez, Heinz Gisslinger, Martin Griesshammer, Hans Hasselbalch, Rajko Kusec, Marie-Caroline Le Bousse-Kerdiles, Nicola L. Liberato, Monia Marchetti, John T. Reilly, Jurgen Thiele

Blood (2005) 106 (8): 2849–2853.

https://doi.org/10.1182/blood-2005-04-1520

Published: 2005

Journal Articles

Treatment with Pegylated Interferon α (PegIntron) for High-Risk Essential Thrombocythemia: Results of a Phase II Study.

Christian Langer, MD, Eva Lengfelder, MD, Jurgen Thiele, MD, Hans M. Kvasnika, MD, Heike Pahl, PhD, Axel Matzdorff, MD, Barbara Stade, Stefanie Schauer, Heinz Gisslinger, MD, Hartmut Dohner, MD, Martin Griesshammer, MD

Blood (2004) 104 (11): 1522.

https://doi.org/10.1182/blood.V104.11.1522.1522

Published: 2004

Journal Articles

Pilot Study of Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Nicolaus Kroeger, MD, Tatjana Zabelina, MD, Heike Schieder, MD, Jens Panse, MD, Francis Ayuk, MD, Natalja Fehse, MD, Boris Fehse, MD, Olga Waschke, MD, Hans M. Kvasnicka, MD, Jurgen Thiele, MD, Axel Zander, MD

Blood (2004) 104 (11): 1512.

https://doi.org/10.1182/blood.V104.11.1512.1512

Published: 2004

NARROW

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Essential Thrombocythemia Versus Pre-Fibrotic/Early Primary Myelofibrosis: Discrimination By Laboratory and Clinical Data

Prefibrotic Primary Myelofibrosis As an Entity Distinct from Other Philadelphia-Chromosome Negative Myeloproliferative Neoplasms - Data from the Austrian Reclassification Project

Survival in Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis - Correlation of Clinical Phenotype with Histomorphological Diagnosis

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

In Contemporary Patients with Polycythemia Vera, Rates of Thrombosis and Risk Factors Delineate a New Clinical Epidemiology

Effects Of Five-Years Of Ruxolitinib Therapy On Bone Marrow Morphology In Patients With Myelofibrosis and Comparison With Best Available Therapy

Correlation Of Longitudinal Blood Counts With Thromboembolic Complications In WHO 2008 Defined Prefibrotic Primary Myelofibrosis

Masked Polycythemia Vera (mPV): Results Of An International Study

Effect Of Treatment With The JAK2-Selective Inhibitor Fedratinib (SAR302503) On Bone Marrow Histology In Patients With Myeloproliferative Neoplasms With Myelofibrosis

A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

Response: Factors considered in the 2008 WHO classification of myeloid neoplasms and acute leukemias

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Glivec/STI571 Treatment Stimulates Megakaryopoiesis and Normalizes PDGF Receptor beta Kinase Expression in Thrombocytopenic Patients with Myeloid Metaplasia with Myelofibrosis.

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

Treatment with Pegylated Interferon α (PegIntron) for High-Risk Essential Thrombocythemia: Results of a Phase II Study.

Pilot Study of Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only